3rd In Vitro Diagnostics London, England, UK 14-15 June 2017

Description:
Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, IVDs 2017 will provide regulatory updates and key industry feedback from leading IVD manufacturers within this complex and ever-changing landscape.

Through a series of presentations from handpicked industry experts and Notified Bodies, the 2017 event will prepare attendees for the challenging times ahead and how to comply with regulatory requirements to ensure direct access to market ensuring the continued growing demand for use and innovation of IVDs over the next decade and beyond. Topics of discussion include: Latest updates on the IVD regulation, the changing role of notified bodies as well as the increase in requirements for clinical evidence.

Price:
BOOK BY MARCH 31ST: GBP 1199
BOOK BY APRIL 28TH: GBP 1299
BOOK BY MAY 31ST: GBP 1399
FROM JUNE 1ST: GBP 1499

Speakers: MHRA, FDA, Johnson & Johnson, LRQA, QARAD, UL, Oxford Impedance Diagnostics, LNE/GMED North America, Ortho Clinical Diagnostics, GS1 Global Office, TUV Rheiland, TÜV SÜD, Berlin Heart GmbH, SIDIV (French Association of In Vitro Diagnostic Industry), DEKRA, Arkray